A novel endogenous CD16-Expressing Natural Killer Cell for cancer immunotherapy

Natural killer (NK) cells, as a potential source for off-the-shelf cell therapy, attack tumor cells with low risk of severe cytokine release syndrome (CRS) or graft-versus-host disease (GvHD). Fcγ receptor IIIA, also known as CD16, further confers NK cells with antibody-dependent cell-mediated cytot...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Zih-Fei, Li, Hao-Kang, Yang, Hsiu-Ping, Lee, Chia-Yun, Tang, Sai-Wen, Lin, Yan-Liang, Hsiao, Shih-Chia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889824/
https://www.ncbi.nlm.nih.gov/pubmed/33644421
http://dx.doi.org/10.1016/j.bbrep.2021.100935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889824/
https://www.ncbi.nlm.nih.gov/pubmed/33644421
http://dx.doi.org/10.1016/j.bbrep.2021.100935

Ejemplares similares